Back

Stroke prevention in sub-populations of patients with non-valvular atrial fibrillation.

26 August 2022 (15:50 - 16:05)
Organised by:
Congress Presentation Part of: Real-world evidence in practice: stroke prevention with non-vitamin K oral anticoagulants in patients with non-valvular atrial fibrillation Atrial Fibrillation (AF) Open Access ESC Congress 2022

About the speaker

Photo
Professor Gregory Yh Lip

University of Liverpool, Liverpool (United Kingdom of Great Britain & Northern Ireland)

3 More presentations in this session

Presentation thumbnail
What can robust real-world evidence bring to the table?
Professor G. Lip (Liverpool, GB)
Slides Video
Presentation thumbnail
Real-world evidence complements randomised controlled trial data to inform daily clinical practice.
Doctor S. Deitelzweig (New Orleans, US)
Slides Video
Presentation thumbnail
Audience participation.
Professor G. Lip (Liverpool, GB)
Slides Video

Access the full session

Session thumbnail
Real-world evidence in practice: stroke prevention with non-vitamin K oral anticoagulants in patients with non-valvular atrial fibrillation
Video

The Event

Event poster

ESC Congress 2022

26 August 2022 15:50 CET
You may be interested in
thumbnail
Congress Presentation
State-of-the-art lecture on stroke and bleeding risk in atrial fibrillation: walking the tight rope
thumbnail
Webinar
Balancing stroke and bleeding risks in patients with AF and concomitant coronary artery disease, malignancy, chronic kidney disease, or frailty
thumbnail
Webinar
Anticoagulation challenges in older subjects with multimorbidity

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources